There are currently no known outstanding effects for the Health and Care Act 2022, Paragraph 118.
118(1)Section 223G (means of meeting expenditure of clinical commissioning groups out of public funds) is amended as follows.
(2)In the heading, for “clinical commissioning groups” substitute “integrated care boards”.
(3)In subsection (1)—
(a)for “clinical commissioning group” substitute “integrated care board”;
(b)for “the group”, in both places it occurs, substitute “the board”.
(4)In subsection (2)—
(a)for “a clinical commissioning group” substitute “an integrated care board”;
(b)in paragraph (a), for “clinical commissioning group” substitute “integrated care board”.
(5)In subsection (3)—
(a)for “a clinical commissioning group” substitute “an integrated care board”;
(b)for “the group” substitute “the board”.
(6)In subsections (5) and (6), for “a clinical commissioning group” substitute “an integrated care board”.
(7)In subsection (7), for “clinical commissioning groups” substitute “integrated care boards”.
(8)Omit subsection (8).
Commencement Information
I1Sch. 4 para. 118 not in force at Royal Assent, see s. 186(6)
I2Sch. 4 para. 118 in force at 1.7.2022 by S.I. 2022/734, reg. 2(a), Sch. (with regs. 13, 29, 30)
Mae’r holl gynnwys ar gael dan Drwydded Llywodraeth Agored v3.0 ac eithrio ble nodir yn wahanol. Yn ychwanegol mae’r safle hwn â chynnwys sy’n deillio o EUR-Lex, a ailddefnyddiwyd dan delerau Penderfyniad y Comisiwn 2011/833/EU ar ailddefnyddio dogfennau o sefydliadau’r UE. Am ragor o wybodaeth gweler ddatganiad cyhoeddus Swyddfa Gyhoeddiadau’r UE ar ailddefnyddio.
